BioCentury
ARTICLE | Clinical News

EGFR pharmDx kit regulatory update

October 9, 2006 7:00 AM UTC

FDA approved a PMA for Dako's EGFR pharmDx kits to assess patient eligibility for Vectibix to treat colorectal cancer. Vectibix panitumumab is marketed by Amgen Inc. (AMGN, Thousand Oaks, Calif.). D...